Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on the Hong Kong Stock Exchange at HK$44 ...

This shift in variant dominance has led to a 28% rise in infections in Singapore during the week ending May 3, 2025.

Health authorities in India are monitoring reports of rising Covid-19 cases in Singapore and Hong Kong, but fresh concerns ...

Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, as a resurgent ...

Several Southeast Asian countries, including Singapore, China, Thailand, and Hong Kong, are experiencing a resurgence of ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

As Covid-19 cases surge in parts of Asia, including Singapore and Hong Kong, Indian health authorities have ramped up ...

Asian countries such as Singapore and Hong Kong have noted a surge in Covid-19 cases over the last few weeks. Health ...

Several parts of Asia, like Hong Kong, Singapore, China and Thailand, are seeing a sharp surge in the number of coronavirus ...

In response to growing global concerns over a surge in Covid-19 cases, a review meeting concluded that the situation in India ...

By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals will price its shares ...